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Antibiotic resistance 
During the last decades, public health service has been facing an increasing number 
of antibiotic resistant pathogens impairing the successful treatment of infectious 
diseases (Neu, 1992). Today, multi-resistant bugs represent a considerable threat to 
society. Since the "golden antibiotic age" in the 1950s, we observe the alarming trend 
that the number of new antibiotics decreases, while bacteria simultaneously grow 
resistant to more and more drugs (Hart, 1998). Besides several factors like the 
careless use of antibiotics, the ability of bacteria to protect themselves in a variety of 
ways has made resistant pathogens arise. As in general, available antibiotic drugs 
act bactericidally or at least bacteriostatically, the bugs are forced to develop 
mechanisms to survive. This so called “selective pressure” promotes the onset of 
resistance against an antibiotic treatment. Especially in case of β-lactam antibiotics 
like ampicillin, carbenicillin, or amoxicillin, a more than 900-fold increase in the 
formation of different β-lactamases has been observed since the 1970s. In addition to 
these drug-degrading enzymes, the bacterial resistance machinery comprises efflux 
systems, target alterations, and the establishment of alternative metabolic pathways 
(reviewed by Davies and Davies, 2010). The basis for those phenotypes is formed by 
resistance factors, the so-called "r genes", which can be acquired by bacteria 
through, for example, spontaneous mutation or horizontal gene transfer (reviewed by 
Bennett, 2008). The latter is critical for spreading different resistance factors amongst 
various bacterial species creating the feared "superbugs" like the pan-resistant 
microorganism Vibrio cholerae (Lipp et al., 2002; Davies and Davies, 2010). These 
facts demand novel concepts in antimicrobial drug therapy. In recent years, 
compounds that impair bacterial pathogenicity rather than their viability have 
attracted more and more attention. The desired benefit of this approach is reduction 
of selective pressure making the occurrence of resistance less probable. 
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Pseudomonas aeruginosa 
 
The Gram-negative opportunistic pathogen Pseudomonas aeruginosa (PA) is a rod-
shaped microorganism prevalent in nosocomial infections and burn wounds. PA is 
ubiquitarily present in the environment and its arsenal of adaptive mechanisms allows 
the colonization of various surfaces under manifold conditions. Especially, plants and 
soil are considered an endless reservoir of Pseudomonades (Green et al., 1974). 
Additionally, PA is one of the most frequently found germs regarding hospital- 
acquired infections (Jarvis and Martone, 1992). Studies have shown the presence of 
the bacterium in sinks, on metal surfaces, floors, and the hands of nurses (Chitkara 
and Feierabend, 1981). Severe infections with this opportunistic pathogen are 
favored in individuals with a hampered immune defense like HIV patients (Franzetti et 
al., 1992) or people undergoing chemotherapeutical treatments (Bendig et al., 1987; 
Lyczak et al., 2000). Furthermore, burn wound victims have a high prevalence for the 
occurrence of PA- associated infections due to a damaged, no longer protecting skin 
layer (reviewed by Bodey et al., 1983) that facilitates bacterial invasion of the host. A 
set of various secreted virulence factors causing host immune modulation and tissue 
damage makes this pathogen a major threat especially for patients suffering from 
cystic fibrosis (CF). (Lyczak et al., 2000; Davies, 2002) Lacking the proper 
mucociliary clearance, these patients have a high prevalence for chronic, persistent 
PA infections affecting bronchia and the deep lung. Besides the Gram-negative cell 
envelope, which depicts the first barrier for antibiotic agents, this pathogen uses a 
variety of multidrug efflux pumps (reviewed by Li and Nikaido, 2009) and β-
lactamases (Wolter and Lister, 2013) to withstand an effective treatment. Its ability to 
encapsulate itself within a biofilm protects the bacterial community in an additional 
gel-like barrier during a chronic infection state (Høiby et al., 2010). These facts 
render PA an unneglectable threat that urgently requires new and effective ways of 
treatment. 
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Quorum sensing (QS) 
 
The possibility to survive under difficult conditions is favored by cooperation. In fact, 
this is true for most organisms including animals, humans, and also bacteria. While 
the most common form of communication is based on the creation of sounds and 
noises, microorganisms have developed their own language. Both, Gram-positive 
and Gram-negative pathogenic species such as Burkholderia, Vibrio, and 
Pseudomonas - only to name a few - are capable of organizing their group behavior 
with the help of a complex, small molecule-based system called “quorum sensing” or 
QS. This system acts as a communication network between the single microbes and 
allows a directed cell-to-cell crosstalk. Small molecules, the so-called autoinducers 
(AIs) or signal molecules, are synthesized and secreted by each cell. With increased 
cell numbers in a population, these AIs reach a certain threshold concentration. In 
neighboring bacteria as well as in an intrinsic autoregulatory way, the signal 
molecules bind to intracellular target receptors activating the transcription of different 
genes associated e.g. with virulence factors. In case of PA, the QS network 
comprises three major regulatory subsystems, namely, the las, the rhl, and the 
Pseudomonas Quinolone System (PQS system). Recently, a fourth regulatory 
system named the integrated quorum sensing system (IQS) that is able to mimic 
some functions of the las system (Lee et al., 2013) has been reported (Figure 1). 
Basically, the regulatory systems consist of a signal synthase, and an intracellular 
response unit. It was shown that, especially in acute infection states, the QS system 
is highly active creating a huge amount of virulence factors. Remarkably, QS is 
down-regulated after PA has established a chronic infection state (van Delden and 
Iglewski, 1998) accompanied by biofilm formation and the presence of persister cells. 
Recently, an overview on the complexity and the hierarchy of the different PA QS 
systems was given (Lee and Zhang, 2015). The present thesis hereby focuses 
especially on the PQS QS system. 
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Figure 1: Organization and hierarchy of the four QS systems. Each system is composed of a signal 
molecule synthesis machinery (lasI, AmbB-E,RhlI, and PqsA-E), autoinducer (OdDHL, IQS, BHL, and 
PQS/HHQ), and receptor (RhlR, IqsR, LasR and PqsR). Stimulating effects are indicated as thick 
green arrows. Inhibitory effects are marked as red line. Figure was modified, based on (Lee and 
Zhang, 2015). 
 
Virulence factors and biofilm formation 
 
PA evokes its pathogenic effects via a set of different virulence factors. Besides cell-
associated factors like pili and flagella, which are needed for adhesion and motility of 
the bacterium, it makes use of  a variety of secreted factors like proteases, 
siderophores, pyocyanin, and hydrogen cyanide as summarized in a recent review 
(Strateva and Mitov, 2011). These enable the microorganism to disturb the human 
immune system, circumvent antibiotic treatment, and compete with other bacteria for 
nutrition sources. This finally favors its persistent survival in a variety of 
environmental niches (Lyczak et al., 2000). 
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Pyocyanin 
 
The virulence factor pyocyanin is one of the most conserved virulence factors among 
the Pseudomonas species, produced by more than 90% of the isolated strains 
(Smirnov and Kiprianova, 1990). Its synthesis involves a complex pathway 
comprising the phzA-G operons as well as the phzH, phzM, and phzS genes. These 
genes transform the initial substrate chorismate into the phenazine pyocyanin 
(Mavrodi et al., 2001; Ortiz-Castro et al., 2014). This redox-active exotoxin is 
considered as key virulence factor. It exerts pleiotropic effects like, for instance, 
impairment of the cilia in the airway epithelium, immunological cell growth, and 
interference with components of the host’s immune system. In addition to the effects 
targeting the host, it allows Pseudomonas to dominate rivaling microorganisms by 
exhibiting fungicidal and antimicrobial effects as mentioned in a review by Ran et al. 
(Ran et al., 2003). Taken together, pyocyanin is an important part in the virulence 
machinery of this pathogen that facilitates persistence and severe infections. 
 
Proteolytic Virulence Factors 
 
The multiple roles of elastase as virulence factor during the PA-associated infection 
processes have been reviewed in detail by several groups (Wretlind and Pavlovskis, 
1983; Galloway, 1991). The elastases A (LasA) and B (LasB) of PA are secreted 
proteases that are especially relevant during the acute infection state (van Delden 
and Iglewski, 1998). Among other effects these elastases take part in the 
degradation process of human elastin, an important component of the lung tissue, in 
a cooperative manner (Galloway, 1991). The loss of elastin is directly connected with 
a hindrance in lung tissue and blood vessel elasticity leading to tissue damage in the 
human host. Additionally, elastase has been shown to destroy surfactant proteins, 
namely SP-A and SP-D, both important players in host’s immune reaction processes 
(Wright, 2005). In vivo studies conducted by Giannoni et al. further demonstrated that 
SP-A and AP-D strongly enhance pulmonary clearance of PA in a mouse model 
(Giannoni et al., 2006). Studies performed by Woods and coworkers (Woods et al., 
1982) revealed a reduced virulence of PA isolates lacking proper elastase activity. 
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Furthermore, such mutants were shown to become more easily cleared from the 
host’s airways than the native, elastase-possessing strain (Blackwood et al., 1983). 
In summary, elastase fulfills a major role in PA pathogenicity rendering it a powerful 
bacterial tool to combat the host’s immune system and allow persistence of the 
bacterial community.  
 
Motility Factors 
 
The initial colonization and later spreading of a pathogen requires the ability to be 
mobile. In bacteria such as PA, this task is not only fulfilled by flagella and pili but 
also by excreted fatty films allowing them to “slide” along the tissue they colonize 
(reviewed in Strateva and Mitov, 2011). The pili of PA are of particular importance in 
the first step of the colonization process. As cell-associated virulence factors they 
recognize the solid cell surface of the host aiding in initial attachment of the 
pathogen. These pili also give PA the ability of twitching motility (Bradley, 1980). 
Furthermore, these cell-associated factors do not only favor a host- bacteria but also 
interbacterial contacts. This renders the pili an important feature in the process of 
biofilm formation (O'Toole and Kolter, 1998). In addition to their role in the bacterial 
attachment, recently, Persat and coworkers demonstrated that the type IV pili are 
also involved in the regulation of the virulence factor machinery (Persat et al., 2015). 
However, the movement of PA does not only depend on these cell- associated 
structures. As mentioned above, the organism surrounds itself with a slimy layer to 
slide along the cell surfaces. Of the various components that are forming this layer, 
the rhamnolipids (RLs) are of particular interest in the anti-virulence therapy. As 
summarized in diverse representative reviews (Soberón-Chávez et al., 2005; Abdel-
Mawgoud et al., 2010), RLs are present as a mixture of different RL congeners, the 
composition of which varies among distinct Pseudomonas strains. In PA, the RLs 
synthesis is controlled by two operons carrying the rhlAB and rhlC genes, 
respectively. The regulation of these genes directly depends on the rhl QS system, 
but has also been shown to be under indirect control of the PQS system (Diggle et 
al., 2003). The excreted RLs fulfil several distinct functions in the bacterial 
environment. In addition to their contribution to pathogenicity, they also render the 
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bacteria able to survive under difficult circumstances. Due to their amphiphilic 
character, these compounds allow the uptake of nutrition factors and substrates that 
possess poor solubility such as n-alkanes. Like elastase and pyocyanin (Wilson et 
al., 1988; Jaffar-Bandjee et al., 1995), high amounts of rhamnolipis can also be found 
in the sputum of patients that have fallen ill with CF. Kownatzki et al. were the first 
that drew a connection between the amount of rhamnolipids produced by PA and the 
declined health status of infected patients (Kownatzki et al., 1987). Reviews report 
several effects affecting the host ranging from hemolytic activity to cytotoxic effects 
on different immune cells (Abdel-Mawgoud et al., 2010). Last but not least, 
rhamnolipids are also involved in the biofilm formation as they favor primary cell-
adhesion due to an increase in surface hydrophobicity. Taken together, these 
observations render the RLs an important part in pathogenicity and bacterial survival. 
Hydrogen Cyanide  
 
Various bacteria, including Burkholderia, Chromobacterium, and Pseudomonas 
species form hydrogen cyanide (HCN) during the “bacterial cyanogenesis”. This toxic 
virulence factor evokes strong inhibition of the cellular respiratory chain and, as an 
effect, causes cell growth inhibition or –killing. Studies revealed that sputum samples 
of patients suffering from cystic fibrosis contained up to 130 µM of HCN excreted by 
PA (Ryall et al., 2008). Due to its various effects on cells, HCN is believed to be the 
primary toxic virulence factor secreted by PA. It caused e.g. increased mortality rates 
in a nematode based infection model (Gallagher and Manoil, 2001). Furthermore, 
mutational studies conducted by Gallagher and coworkers indicate that an 
interference with PA’s PQS system not only reduces the  virulence factor pyocyanin, 
but also decreases HCN production (Gallagher et al., 2002). This fact furthermore 
renders PQS QS an attractive target for novel therapeutics.  
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Biofilm 
 
One of the major barriers for agents targeting PA is represented by the biofilm matrix. 
This barrier consists of various proteins, extracellular nucleic acids, RLs, and 
polysaccharides, mainly the alginate (Flemming and Wingender, 2010; Høiby et al., 
2010). This enables the bacteria not only to protect themselves against antibiotic 
treatment but in addition against the host’s immune defensive mechanisms. Besides 
the protecting aspects, the bacteria use proteins, embedded in the extracellular 
matrix, to ensure access to vital nutrition factors by degrading biopolymers that can 
be used as carbon sources. Amongst other factors, this set of distinct enzymatic and 
non-enzymatic proteins also contributes to virulence and structural integrity of the 
biofilm (Flemming and Wingender, 2010). Besides the virulence factor producing 
cells, this protective film harbors cells that remain in a “sleeping mode”. These 
dormant cells possess a low rate of metabolism and cell division, turning them less 
sensitive against an antibiotic treatment (Lewis, 2008). In vitro studies have shown 
that the process of biofilm development occurs in a stepwise manner starting with the 
bacteria’s adhesion followed by different maturation stages. In the final state, the 
grown bacterial mass is released again allowing further spreading of the infection 
(Sauer et al., 2002; Davies, 2003; Wagner et al., 2016) (Figure 2).  
 
 
Figure 2: The process of in vitro biofilm formation. Figure was modified, based on (Seong-Cheol et al., 
2011). 
From left to right: reversible adhesion  irreversible adhesion  microcolony 
formation  biofilm maturation  dispersion of the bacteria 
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The transcriptional regulator PqsR 
 
Each QS system has its specific signal molecules and its respective regulators 
responsible for gene transcription. In case of the PQS system, this role is played by 
the central transcriptional regulator MvfR (multiple virulence factor regulator), also 
called PqsR (Pseudomonas quinolone signal receptor), a 37.2 kDa membrane-
associated protein. PqsR belongs to the LysR type transcriptional regulator family 
(LTTR), which represents the largest group of bacterial transcription factors (Cao et 
al., 2001; Zaim, 2003). Like many additional members of this protein family, PqsR is 
composed of a C-terminal coinducer-binding domain and an N-terminally located 
DNA-binding domain formed by a helix-turn-helix (HTH) motif (Schell, 1993; Xu et al., 
2012; Kefala et al., 2012). Under addition of its coinducers PQS (Pseudomonas 
Quinolone Signal) or HHQ (2-heptyl-4(1H)-quinolone), PqsR promotes the 
transcriptional activation of the pqsABCDE operon that is responsible for the 
synthesis of HHQ and PQS. In this way PqsR activity is controlled in an autoinductive 
manner. (Figure 3) Further regulated genes involve the phnAB operon, that takes 
part in the phenazine biosynthesis (Cao et al., 2001). Furthermore, it indirectly 
regulates numerous genes promoting bacterial pathogenicity as shown by a 
transcriptome analysis of a PqsR- deficient knockout strain (Déziel et al., 2005). A 
blockade of PqsR by antagonistic compounds has been shown to reduce PA 
pathogenicity and persister cell formation leading to an enhanced survival rate in 
different animal infection models (Lu et al., 2014b; Starkey et al., 2014). 
The present thesis was focused on the characterization of small molecules 
modulating the PQS receptor PqsR. Studies carried out by Déziel et al. and Cao et 
al. (Cao et al., 2001; Déziel et al., 2005) showed that, amongst others, PqsR 
regulates pyocyanin and elastase B production. Mutational studies revealed a 
complete deficiency in pyocyanin production for strain lacking PqsR activity, leading 
to a reduced pathogenicity (Déziel et al., 2004; Xiao et al., 2006a). In addition to 
pyocyanin, elastase and rhamnolipids are also decreased in a PqsR mutant 
genotype (Diggle et al., 2003). Taken together, these findings render PqsR an 
attractive target for the anti-virulence therapy. 
Besides the PqsR antagonists, several so called “quorum sensing inhibitors” (QSIs) 
are currently being developed by several groups. 
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Figure 3: The role of PqsR within the quorum sensing network The transcriptional regulator PqsR 
activates the gene transcription of the pqsA-E operon upon induction by its autoinducer PQS. The 
figure was designed by my colleague Dr. Martin Empting. 
 
QS inhibitors targeting PQS QS 
 
The so-called QSIs are derived from distinct compound classes. The molecular 
diversity reaches from small molecule inhibitors to large molecular weight natural 
compounds. To date, numerous QSIs are published that have been developed by 
several groups. Basically, these inhibitors can act via a) an interference with the 
signal molecule synthesis b) by targeting the signal molecules themselves c) a 
blockade of the signal receptors or involving multiple of the just mentioned 
mechanisms (Maurer et al., 2015; Wagner et al., 2016; Thomann et al., 2016). For 
the PQS system, case a) is represented by compounds that inhibit the formation of 
the two main PqsR ligands, namely HHQ and PQS. HHQ is formed in a complex 
synthesis pathway involving the enzymes PqsA – PqsE (Coleman et al., 2008; 
Dulcey et al., 2013; Drees and Fetzner, 2015). The final step involves the 
hydroxylation of HHQ to form its potent derivative PQS, which is conducted by the 
FAD- dependent monooxygenase PqsH (Gallagher et al., 2002; Déziel et al., 2004). 
Compounds addressing the first step in the HHQ synthesis, namely the PqsA-
mediated conversion from anthranilate to anthraniloyl-coenzyme A (Coleman et al., 
2008), can act either as “false substrates” that are converted into “false products” or 
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inhibitors of PqsA. This approach efficiently reduced PQS levels in PA (Calfee et al., 
2001; Lesic et al., 2007). Several inhibitor classes targeting the PqsD enzyme, which 
catalyzes the second step in the HHQ synthesis, showed signal molecule reduction 
and anti-biofilm activities (Storz et al., 2012; Storz et al., 2014; Allegretta et al., 2015).  
To target the autoinducer molecules themselves, different groups reported 
approaches including enzymatic degradation and antibody- mediated absorption. For 
the PQS system, Pustelny et al. (Pustelny et al., 2009) were able to show that the 
dioxygenase Hod was able to degrade the signal molecule PQS, leading to 
decreased virulence in a plant model. In addition to PQS system-targeting agents, 
numerous groups have undertaken efforts in developing a variety of compounds 
addressing the las and rhl QS systems to fight PA. An overview of different QSIs and 
treatment strategies targeting the pathogen’s different regulatory systems was 
recently given in detail by Wagner and Sommer et al. (Wagner et al., 2016). 
To disturb the signal transduction, another option is antagonizing PqsR, which serves 
as the response unit within the PQS QS system. Both, ligand (HHQ)-based 
derivatives and structurally unrelated compounds have shown promising activities in 
in cellulo and in vivo models. The blockade of PqsR successfully provided a proof-of-
concept for an anti-virulence therapy against PA infections (Hodgkinson et al., 2010; 
Klein et al., 2012; Lu et al., 2012; Zender et al., 2013; Ilangovan et al., 2013; Lu et 
al., 2014b; Starkey et al., 2014). The application of dual inhibitor targeting PqsD and 
PqsR has recently been shown to be effective in protecting Galleria mellonella larvae 
from a lethal infection further highlighting the benefit of a PQS system blockade to 
reduce the bacteria’s pathogenicity (Thomann et al., 2016). Furthermore, such a dual 
approach or the directed blockade of PqsR, have turned out to be more beneficial 
than just inhibiting the autoinducer synthesis machinery. Storz et al discovered potent 
inhibitors of PqsD, that were able to slightly reduce the virulence factor pyocyanin, 
but only at very high concentrations (Storz et al., 2012; Thomann et al., 2016). 
Starkey and coworkers recently reported the, to date, most potent antivirulence 
compound for PA that is a PqsR antagonist (Starkey et al., 2014).   
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Assay systems 
 
For the investigation of the cellular potency and the functional characterization of the 
presented compounds, mainly two assay variants were used. In case of the cellular 
effects, we used a ß-galactosidase-based reporter gene system in both, E. coli DH5α 
and P. aeruginosa PA14 ΔpqsA strains. For the mechanistic studies described in 
chapter 1, a cell-free system using the principle of fluorescence polarization (FP) was 
applied. 
 
β- Galactosidase reporter gene assay 
 
Reporter gene assay systems are used throughout the drug development process 
and are available in many different configurations that are suitable for eukaryotic and 
prokaryotic cell setups that have been addressed in several reviews (Bronstein et al., 
1994; Naylor, 1999; New et al., 2003). Reporter gene readouts might be bacterial 
survival, formation of colored products, or the expression of fluorescing molecules. 
This technique is commonly used to monitor gene transcription-or translation-
regulated effects in the cellular environment. Basically, these systems can be divided 
into invasive and non-invasive assays. The non-invasive methods, like Green 
Fluorescent Protein (GFP) or Luciferase expression systems allow readout without 
the lysis of the cells. The reporter gene system used in the present thesis is based on 
the expression of the enzyme β-galactosidase and belongs to the invasive reporter 
gene methods. It is a popular reporter gene as it allows an easy colorimetric readout. 
In contrast to GFP-based transcription products, the β-galactosidase requires the 
addition of a cleavable substrate to monitor the activity. The underlying mechanism 
behind the ß-galactosidase reporter system is shown in Figure 4. Expression of the 
lacZ gene is triggered by the transcriptional regulator. After expression of the 
enzyme, the cells have to be lysed to allow interaction between the substrate ortho-
nitrophenol β-D-galactopyranoside (ONPG), which is then cleaved into β-galactose 
and the yellow ortho-nitrophenol (ONP). The absorption of the formed ONP can be 
measured at 420 nm. 
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Figure 4: Principle of the ß-galactosidase reporter gene assay. 
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Fluorescence polarization assay 
 
The usage of FP in screening processes has been thoroughly investigated in the 
recent years. The range of application is broad as this method allows investigation of 
diverse biomolecular processes such as protein - DNA, protein- ligand, and protein- 
protein interactions (Jameson and Sawyer, 1995; Checovich et al., 1995; Hill and 
Royer, 1997; Huang, 2003). The assay is carried out in a cell- free environment using 
purified protein and fluorescent-labeled probes of either ligand or protein. Here, a 
variety of different labeling probes can be applied to ensure best signal strength and 
minimized interference. In this thesis, FP competition experiments were used to 
investigate PqsR- DNA interactions under simultaneous addition of different PqsR 
ligands. Such an approach requires purified receptor, a labeled DNA probe, and 
diverse unlabeled competitor DNAs. Figure 5 explains the underlying mechanism of 
FP. 
 
Figure 5: Mechanism of fluorescence polarization to monitor protein- ligand interactions.  
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Every novel compound determined for the treatment of a disease needs a reliable 
characterization in the first instance. In case of the antagonistic compounds targeting 
the PqsR receptor, information about their functionality and potency form the basis in 
the drug discovery process. A central part of the present thesis is dedicated to 
achieve this goal: the development of cell-based reporter gene systems in both, E. 
coli and P. aeruginosa. To avoid effects caused by the complex QS regulatory 
cascade that is present in PA, the E. coli assay will be chosen as initial test system. 
Additionally it lacks Pseudomonas-specific pharmacokinetic (PK) issues like e.g. PA 
enzymes. This provides a sensitive way to monitor direct effects on the target itself. 
In a second step, selected antagonists will be further evaluated in the more complex 
P. aeruginosa- based reporter gene system. The possibility of a metabolization by PA 
enzymes shall be investigated as a reason for an altered potency and functionality 
observed for compounds exhibiting decreased activity in PA. This goal can be 
achieved by using different PA mutant strains in combination with LCMS-MS based 
methods. In order to understand the molecular mechanisms behind an agonistic or 
inverse agonistic functionality, an in vitro fluorescence polarization based assay shall 
be developed. 
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Chapter 1: “Molecular mechanism of inverse agonism on the 
global virulence regulator PqsR for repressive control in 
Pseudomonas aeruginosa” 
 
The following persons contributed to this chapter: 
Benjamin Kirsch:  
Constructed, expressed and purified the protein, conducted the fluorescence 
polarization experiments and the reportergene assays in E.coli and P.aeruginosa.  
 
Michael Zender:  
Synthesized compound 2 and performed the ITC titration experiment.                          
 
Simone Amann:  
Assisted in conducting the reportergene assays. 
Introduction  
The human pathogen P. aeruginosa causes severe acute and chronic infections of 
wounds and of the lung especially in immunocompromised individuals (e.g. HIV). 
Furthermore, it is most prevalent in patients suffering from cystic fibrosis causing 
increased mortality (Davies, 2002; Sordé et al., 2011). Emerging high-level antibiotic-
resistance of this pathogen towards common treatment (Bonomo and Szabo, 2006), 
results in an urgent demand for novel anti-infectives. A promising strategy is to target 
non-vital functions associated with the pathogenicity of a bacterium, thus, exerting a 
reduced selective pressure and resistance development. PqsR, also known as MvfR 
(multiple virulence factor regulator), is a global transcriptional regulator within the cell-
to-cell signaling network of P. aeruginosa. In association with two other N-acyl L-
homoserine lactone (AHL)–dependent quorum sensing (QS) systems (las and rhl), 
the Pseudomonas quinolone signal (PQS) QS is involved in the regulation of 
numerous genes that function in controlling virulence and pathogenesis, biofilm 
formation and antibiotic resistance via the expression of efflux pumps (Déziel et al., 
2005) (Figure 1).  
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Figure 1: The global regulator PqsR has key functions in P. aeruginosa pathogenesis. Upon binding 
of its co-inducer PQS, PqsR directly binds to the promotor of the pqsABCDE operon thus driving the 
biosynthesis of HHQ, the PQS precursor. PqsR´s direct or indirect regulon involves genes for the 
production of virulence factors, biofilm and antibiotic efflux. Compound 1 is a potent PqsR antagonist 
that represses the expression of the virulence factor pyocyanin and strongly reduces the mortality rate 
caused by P. aeruginosa in animal models (Lu et al., 2014b). 
PqsR is a member of the largest group of prokaryotic lysR-type transcriptional 
regulators (LTTR) and, as such, composed of a C-terminal co-inducer recognition 
domain and a highly conserved N-terminal DNA binding domain containing a helix-
turn-helix motif (Kefala et al., 2012; Xu et al., 2012). LTTRs exist and function as 
dimers or tetramers or even higher oligomerization states (Hryniewicz and Kredich, 
1994; Maddocks and Oyston, 2008; Zhou et al., 2010; Gong and Maser, 2012; 
Vadlamani et al., 2015) that interact with several mostly inverted repeat (pseudo-
palindromic) sequences on target DNA (Goethals et al., 1992). The presence of a co-
inducer triggers a 6- to 200- fold enhancement of gene transcription by increasing 
affinity to target sequences near the -35 bp region within the promotor (Dubbs et al., 
2004; Schell, 1993). In case of PqsR, transcriptional activation requires the binding of 
the co-inducer PQS (Pseudomonas quinolone signal; 2-heptyl-3-hydroxy-4(1H)-
quinolone) or its biological precursor HHQ (2-heptyl-4(1H)-quinolone) which both 
possess multifunctional roles in the QS regulation (Wade et al., 2005, Xiao et al., 
2006; Diggle et al., 2007). PqsR directly binds to the pqsA promotor region and 
activates the transcription of the HHQ biosynthetic operon pqsABCDE in an 
autoregulatory manner (Wade et al., 2005, Xiao et al., 2006; Xiao et al., 2006a; 
Diggle et al., 2007). HHQ is converted into the more potent ligand PQS by PqsH 
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which is independent of PqsR (Gallagher et al., 2002; Déziel et al., 2004). Known to 
control a large set of virulence-associated genes, blockers of this regulator have 
been developed by us and other groups (Lu et al, 2012; Ilangovan et al., 2013; 
Zender et al., 2013; Lu et al., 2014a; Lu et al. 2014b; Starkey et al., 2014). Their 
effectiveness as anti-virulence agents has been proven in animal models (Lu et al., 
2014c; Starkey et al., 2014). Interestingly, it has been shown that a potent PqsR 
antagonist can reduce the formation of antibiotic-tolerant persister cells (Starkey et 
al., 2014). The biochemical characterization of these PqsR antagonists implicated the 
investigation of PqsR-ligand interactions by state-of-the-art methods like Isothermal 
Titration Calorimetry (ITC) (Klein et al., 2012; Zender et al., 2013), Surface Plasmon 
Resonance (SPR) (Klein et al., 2012; Zender et al., 2013), and X-ray crystallography 
(Ilangovan et al., 2013). The functional response to compounds has been monitored 
in reporter gene assays and by the determination of extracellular 4-alkyl quinolone 
levels in P. aeruginosa. However, the mechanism of the modulation of PqsR activity 
by a ligand (agonist or antagonist) on a molecular basis has not been investigated, 
yet. The present study is directed to explore the process associated with co-inducer 
triggered transcriptional activation and antagonist-mediated repression of this 
important virulence regulator. This objective led us to determine the, to date uncertain 
oligomerization state of full-length PqsR in solution and investigate the binding 
pattern to promotor DNA using fluorescence polarization in combination with mutated 
nucleotides. Furthermore, we sought to shed light on the impact of different ligands 
on protein-DNA interaction and demonstrate the relevance of our in vitro results in life 
bacteria. Our studies revealed a tetrameric form in solution for the full-length MBP-
tagged PqsR that occupied two distinct binding sites on the promotor DNA when 
bound by its co-inducer PQS. In contrast, the unliganded and antagonist- liganded 
form showed a different binding pattern. Notably, the antagonist enhanced DNA- 
binding affinity of PqsR one of the identified interaction sites on the target DNA in our 
in vitro setup. This new binding region (site I) turned out to be mandatory for PqsR 
activity in P. aeruginosa using a mutated reporter gene construct. 
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A                                                                                        B 
Results 
Characterization of PqsR 
Soluble and active full-length PqsR was overexpressed and purified with a maltose-
binding protein (MBP) tag at its C-terminus. ITC was performed to ensure an intact 
ligand binding domain for the obtained fusion protein (Figure 2). 
 
 
 
 
 
 
 
 
Figure 2: ITC titration curve of PqsR and 4-tert-butyl benzamide 
To gain insight into the oligomerization state of PqsR in solution, a protein cross-
linking study using the reagent bis(sulfosuccinimidyl)suberate (BS3) was conducted. 
Figure 3: Determination of the oligomerization state of PqsR by protein cross-linking using BS3. 
Reactions (consisting of 12 µg of purified PqsR) were separated on a 12% SDS-PAGE. Lane 1: 
HiMark prestained protein standard (ThermoFisher Scientific, Germany), lane 2: free PqsR, lane 3-10: 
quenching of the cross-linking reaction after 2 min time intervals. 
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The cross-linking reaction consisting of purified PqsR and a five-fold excess of BS3 
was stopped after several time points (0-14 min). The electrophoretic separation of 
the reaction mixture on a SDS-polyacrylamide gel revealed that the tetrameric state 
of PqsR (332 kDa, Figure 3A) is likely the predominant form in solution. On the 
contrary, the dimeric species (166 kDa) is barely visible.  
This finding corresponds to many other members of the LTTR family possessing a 
tetrameric quaternary structure (Miller and Kredich, 1987; Schell, 1990; Hryniewicz 
and Kredich, 1994; Muraoka et al., 2003; Vadlamani et al., 2015). Additionally, we 
investigated the influence of compound 1 (Figure 1), a potent PqsR antagonist, in this 
cross-linking experiment. Interestingly, we did not observe a change in the 
oligomeriziation state of PqsR due to the presence of an equimolar amount of 1 
(5 µM; Figure 3B). 
Binding pattern of PqsR on pqsA promotor and impact of the co-inducer 
In order to explore PqsR binding sites at the pqsA promotor, protein-DNA interactions 
were quantified by fluorescence polarization (FP) experiments. Through biochemical 
mutational studies, Xiao and coworkers previously verified the importance of the 
typical LTTR recognition element (TTCCGACTCGGAA, from -51 to -35 bp relative to 
the transcriptional start site (TSS) of the pqsA gene) for the activation mechanism 
(Xiao et al., 2006a). Thus, initial fluorescence polarization measurements were 
conducted with a fluorescein-labeled, 51 bp DNA fragment that included this 
important region. As depicted in Figure 4, PqsR binds this fragment irrespective of 
the co-inducer PQS with moderate binding affinity. Noteworthy, PQS strongly 
promotes the transcriptional activation of pqsAp-lacZ fusion in reporter gene assay 
(Figure 5A). 
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Figure 4: Fluorescence polarization titration curves. Each probe contained 10 nM of fluorescein-
labeled 51 bp DNA fragment from -64 to –12 bp relative to pqsA TSS supplemented with DMSO as a 
control (Control) or 2 µM PQS (PQS). Protein was added at increasing concentrations (0.007 – 5.6 
µM). Data represent the mean values and standard deviations of one experiment with n=2. 
 
 
 
 
 
 
Figure 5: A Dose-dependent agonistic activity of PQS and inverse agonistic activity of compound 1. 
Reporter gene assay was carried out in E. coli DH5α x pEAL08-2 (Cugini et al., 2007) harboring 
plasmid-borne PqsR and pqsAp-lacZ fusion. Compound 1 acts as inverse agonist as it decreases the 
basal activity. Data represent the mean values and standard deviations of one experiment with n=4. B 
Compound 1 decreases the PQS-induced activity. In the latter case, compound 1 was tested in 
competition to 50 nM PQS. β-galactosidase activity is expressed as factor in relation to the stimulation 
caused by 50 nM PQS (= 1.0). Basal expression level is defined as 0. Data represent the mean values 
and standard deviations of five independent experiments with n=4.  
A                                                                                               B 
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In order to localize more precisely potential PqsR interaction hotspots on DNA, we 
tested a set of serial site-directed mutants of the native pqsA promotor DNA fragment 
in FP competition experiments in the absence and presence of PQS or an antagonist. 
We altered base pair topology of cassettes of six adjacent residues by replacing 
adenine by guanine and cytosine by thymine. By this means, we generated 9 
variants of the native 51 bp oligo and evaluated their affinity. From the data 
summarized in Table 1 and Figure 6, two adjacent PqsR binding sites I and II are 
evident. PqsR binding site I is formed by a 13 bp pseudo-palindromic sequence 
positioned -64 to -52 nucleotides upstream of the pqsA TSS and a second 
palindromic 13 bp binding site II corresponding to the LTTR recognition element is 
located in direct vicinity downstream to site I extending from -51 bp to -39 bp. The 
novel identified site I and additionally the upstream half of site II are bound in the 
absence or presence of any ligand (fragments 1-3) whereas the downstream 
positioned half of site II is only addressed upon binding of PQS (fragment 4). These 
findings render site I acting as a central anchor site, being generally important for 
PqsR-DNA interactions. Site I and II differ in their DNA sequence, but share the 
length and the inverted repeat character of the recognition motif separated by a 3 bp 
spacer. To determine if interaction with site II depends on site I, 5 bp and 10 bp 
spacers were introduced. Both modifications reduced the affinity in the presence of 
PQS by factor 3 to 5 indicating that the vicinity of site I and site II is of importance for 
efficient binding, which might be due to cooperativity. The results for apo PqsR and 
co-inducer-liganded PqsR further support the notion of a two-site transcriptional 
activation model proposed for some members of the LTTR family. According to this 
model, one tetramer is supposed to bind two sites where each site is occupied by 
one dimer of the tetramer (Maddocks and Oyston, 2008). 
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Table 1 Determination of EC50 values derived from FP competition experiments. The native labeled 
DNA fragment was competed with nine mutated pqsA promotor DNA fragments in the absence (Apo) 
and presence of PQS (2 µM) or compound 2 (10 µM). Site I is marked in bold and site II is underlined. 
Replaced residues (A→G, C →T) are marked in blue. EC50 represents the effectiveness of unlabeled 
DNA to compete with the labeled DNA fragment. Data represent mean values and standard deviations 
of at least two independent experiments with n=2. 
 
 
 
 
name sequences of native and artificial promotor DNA fragments 
from  -64 to -12 bp relative to TSS (5´ 3´) 
EC50 
Apo 
[nM]  
EC50 + 
PQS 
[nM] 
EC50 + 
cpd.2 
[nM] 
native CGAAACTTTTTCGTTCGGACTCCGAATATCGCGCTTCGCCCAGCGCCGCTA 183 +/- 
33 
152 +/-  
9 
236 +/- 
66 
1 CGAAGTCCCCTCGTTCGGACTCCGAATATCGCGCTTCGCCCAGCGCCGCTA 568 +/- 
19 
1758 +/- 
464 
472 +/- 
14 
2 CGAAACTCCCCTATTCGGACTCCGAATATCGCGCTTCGCCCAGCGCCGCTA 439 +/- 
38 
512 +/- 
18 
390 +/- 
16 
3 CGAAACTTTTTCGCCTAAGCTCCGAATATCGCGCTTCGCCCAGCGCCGCTA 490 +/- 
46 
572 +/-
24 
502 +/- 
103 
4 CGAAACTTTTTCGTTCGGACCTTAGGTATCGCGCTTCGCCCAGCGCCGCTA 216 +/- 
1 
1372 +/- 
259 
281 +/- 
82 
5 CGAAACTTTTTCGTTCGGACTCCGAATACTATATTTCGCCCAGCGCCGCTA 67 +/-  
5 
63 +/-    
2 
66 +/-     
1 
6 CGAAACTTTTTCGTTCGGACTCCGAATATCGCGCTTTATTTGGCGCCGCTA 118 +/-
27 
135 +/- 
12 
157 +/- 
34 
7 CGAAACTTTTTCGTTCGGACTCCGAATATCGCGCTTCGCCCAGCATTATCA 164 +/- 
12 
143 +/-   
2 
181 +/- 
37 
8 CGAAACTTTTTCGAGCGCTTCGGACTCCGAATATCGCGCTTCGCCCGTGAC 445 +/- 
75 
495 +/- 
58 
N.d. 
9 CGAAACTTTTTCGCGCCGCTAGTTTCGGACTCCGAATATCGCGCTTCGCCC 508 +/- 
36 
687 +/- 
76 
N.d. 
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Figure 6: Graphical view of the results presented in Table 1 showing the factorial impact of the six 
residue mutations on EC50. Factors are calculated in relation to the native DNA fragment (see Table 
1). EC50 values were determined in the absence (Apo form) or presence of PQS or compound 2 (cpd 
2). Native DNA sequence is marked in bold. The mutated six residue nucleotide sequences are shown 
above. Each data point marks the middle of the respective six nucleotide mutation. Data represent the 
mean values and standard deviations of at least two independent experiments with n=2. Numbers 
above each data point refer to the respective DNA fragment number.  
 
PqsR blocker enhances protein-DNA interaction 
The differential functional outcome of PqsR-responsive transcription (activation or 
repression) depends on the type of ligand that interacts with the co-inducer binding 
domain. Recently, our own laboratory reported compound 1 as highly active PqsR 
antagonist with in vivo activity. Analyzing its dose-response curve in our heterologous 
reporter gene assay, we observed characteristics of inverse agonism as evidenced 
by the repression of basal and PQS-induced activity (Figure 5) as well as competitive 
binding to the ligand-binding domain (Lu et al., 2014b). In the presence of compound 
1, we most interestingly observed a strong increase in affinity (Kd > 2 µM vs Kd (+cpd 2) 
= 0.45 µM) for pqsA promotor DNA fragment extending from –85 to –35 bp (Figure 
7).  
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Figure 7: Fluorescence polarization titration curves. Each probe contained 10 nM of fluorescein-
labeled 51 bp DNA fragment from -85 to –35 bp relative to pqsA TSS supplemented with DMSO as a 
control (Control) or 5 µM compound 1 (compound 1). Protein was added at increasing concentrations 
(0.007- 5.6 µM). Data represent the mean values and standard deviations of one experiment with n=2. 
To investigate whether this phenomenon is restricted to quinolone-derived 
compounds, we tested this fragment in the presence of a structurally distinct 
compound class (compound 2; structure undisclosed). This newly discovered PqsR 
inverse agonist possesses improved physicochemical properties and potent inhibitory 
activity towards PqsR, which was determined by the repression of PqsR-mediated 
transcriptional activation in E. coli reporter gene assay and reduction of HHQ 
formation in P. aeruginosa (Table 2). As presented in Figure 8, compound 2 also 
increases the affinity of PqsR to the pqsA promotor fragment in a dose-dependent 
manner. These data encouraged us to further explore the occupancy of PqsR on 
DNA upon binding of an inverse agonist in more detail. 
Table 2 Activity of PqsR inverse agonists on transcriptional activation in E. coli reporter gene assay 
and extracellular HHQ level of P. aeruginosa PA14. Data represent mean values and standard 
deviations of at least two independent experiments with n=4 for reportergene experiments and n=3 for 
HHQ assay. 
Cpd. E. coli reporter gene IC50 [nM] 
 
HHQ in PA14 inhibition [%] 
1 35 ± 4 
 
54% at 15 µM 
2 423 ± 103 
 
33 % at 50 µM 
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Figure 8: Fluorescence polarization titration curves for compound 2. Each probe contained 10 nM of 
fluorescein-labeled 51 bp DNA fragment from -85 to –35 bp relative to pqsA TSS supplemented with 1 
µM protein. Compound 2 was added at increasing concentrations (0 – 100 µM). Data represent the 
mean values and standard deviations of one experiment with n=2. 
 
Determination of inverse agonist-liganded PqsR binding sites by mutational 
analysis 
Serial mutants of the native pqsA promotor fragment (DNA sequences 10-23, Figure 
9/Table 3) were analyzed for their binding capability (Kd) in fluorescence polarization 
competition experiments in the presence of compound 2. Again, we conducted 
exchanges of a set of six residues of the native 51 bp pqsA promotor. Among these 
14 variants (10-23), fragments 10-15 did not considerably alter the affinity (Kd values 
ranging from 28 to 59 nM). In contrast, fragments 16-19 showed a strongly reduced 
binding affinity in the presence of compound 2. These variants harbor mutations 
within the above identified anchor site I with a major impact on protein-DNA 
interaction in case of fragment 17 (Figure 9). Notably, mutations within the 
downstream half of site II did not greatly influence affinity (fragments 22 and 23). 
Mutations within the upstream located side of site II (fragment 19) led to a moderate 
impairment of binding affinities indicating a partial occupancy of this region. Further 
work investigated the minimal DNA sequence length essential for PqsR binding. For 
that purpose, a focused set of truncated DNA fragments was constructed and tested 
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within this in vitro setup in the presence of compound 2. The results confirmed the 
former observations of a partial occupancy of site II (Table 4).  
 
Figure 9: Graphical view of the results shown in Table 3 highlighting the factorial impact of the six 
residue mutations on EC50. Factors are calculated in relation to the native DNA fragment (see Table 
3). Native DNA sequence is marked in bold. The mutated six residue nucleotide sequences are 
indicated above. Each data point marks the middle of the respective six nucleotide mutation. Data 
represent the mean values and standard deviations of at least two independent experiments with n=2. 
Numbers above each data point refer to the respective DNA fragment number. 
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Table 3 Determination of equilibrium constants (Kd) calculated from EC50 values for PqsR and the 
native or artificial pqsA promotor DNA fragments in the presence of compound 2 (10 µM) by 
fluorescence polarization competition experiments. Replaced residues (A→G, C →T) are marked in 
blue. Site I is marked in bold, site II is underlined. Data represent mean values and standard 
deviations of at least two independent experiments with n=2. 
name mutated promotor fragments -85 to -35 bp relative to pqsA TSS 
(5´3´) 
EC50 [nM] Kd [nM] 
native GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTTCGTTCGGACTCCGAATATC 64 +/- 12 28 +/- 6 
10 GGGATTTGTGGTTCTTCTCCCCGAAACTTTTTCGTTCGGACTCCGAATATC 60 +/- 20 27 +/- 9 
10 GGGATTTGTGGTTCTTCTCCCCGAAACTTTTTCGTTCGGACTCCGAATATC 60 +/- 20 27 +/- 9 
11 GAAGCCCACAACCCTTCTCCCCGAAACTTTTTCGTTCGGACTCCGAATATC 47 +/- 20 21 +/- 9 
12 GAAGCCCGTGGTTTCCTCTCCCGAAACTTTTTCGTTCGGACTCCGAATATC 88 +/- 16 39 +/- 7 
13 GAAGCCCGTGGTTCTTTCTTTTGAAACTTTTTCGTTCGGACTCCGAATATC 34 +/- 17 15 +/- 8 
14 GAAGCCCGTGGTTCTTCCTTTTAAAACTTTTTCGTTCGGACTCCGAATATC 112 +/- 10 50 +/- 4 
15 GAAGCCCGTGGTTCTTCTTTTTAGAACTTTTTCGTTCGGACTCCGAATATC 132 +/- 13 59 +/- 6 
16 GAAGCCCGTGGTTCTTCTCTTTAGGACTTTTTCGTTCGGACTCCGAATATC 402 +/- 105 179 +/- 46 
17 GAAGCCCGTGGTTCTTCTCCCCGAAGTCCCCTCGTTCGGACTCCGAATATC 793 +/- 110 352 +/- 49 
18 GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTCTACCTGGACTCCGAATATC 317 +/- 64 141 +/- 29 
19 GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTTCGCCTAAGCTCCGAATATC 344 +/- 24 153 +/- 11 
20 GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTTCGTCTAAGTTCCGAATATC 161 +/- 7 71 +/- 3 
21 GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTTCGTTTAAGTCCCGAATATC 156 +/- 13 69 +/- 6 
22 GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTTCGTTCAAGTCTCGAATATC 80 +/- 36 36 +/- 16 
23 GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTTCGTTCGGACTCTAGGCGTC 36 +/- 9 16 +/- 4 
  
 - 29 - 
 
Table 4 Equilibrium constants (Kd) and EC50 values of truncated pqsA promotor DNA fragments 
determined in the presence of compound 2 (10 µM) by fluorescence polarization competition 
experiments with site I in bold and site II underlined. Data represent mean values and standard 
deviations of at least two independent experiments with n=2. 
 
 
 
 
 
 
 
 
In vivo regulatory role of the identified binding site I 
In addition to the in vitro FP experiments, gene expression experiments were 
conducted to explore the relevance of the novel identified site I in the control of the 
pqsABCDE operon in the whole-cell environment. For this purpose, we introduced six 
site-directed mutations within nucleotides most critical for DNA binding (Table 3, 
fragment 17) and measured the PqsR-mediated expression of β-galactosidase 
activity of pqsAp-lacZ transcriptional fusions in the absence and presence of the 
natural agonist PQS. Initially, the heterologous host E. coli was chosen to decouple 
transcription of the pqsA promotor from the complexity of the native regulation in P. 
aeruginosa. In the absence of any ligand, E. coli strain containing plasmid pEAL08-2 
with mutated binding site I showed a reduced basal expression level of β-
galactosidase compared to wild-type (Figure 10).  
name truncated pqsA promotor fragments (5´ 3´) EC50 [nM] Kd [nM]  
native GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTTCGTTCGGACTCCGAATATC 64 +/- 12 28 +/- 7 
24        GTGGTTCTTCTCCCCGAAACTTTTTCGTTCGGACTCCGAATATC 103 +/- 14 46 +/- 6 
25              CTTCTCCCCGAAACTTTTTCGTTCGGACTCCGAATATC 107 +/- 14 48 +/- 6 
26                     CCGAAACTTTTTCGTTCGGACTCCGAATATC 225 +/- 2 100 +/- 1 
27 GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTTCGTTCGGACTC 79 +/- 5 35 +/- 2 
28 GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTTCGTTCGGA 230 +/- 16 102 +/- 7 
29 GAAGCCCGTGGTTCTTCTCCCCGAAACTTTTTCGTTC > 3000 > 1332 
30        GTGGTTCTTCTCCCCGAAACTTTTTCGTTCGGACTC 132 +/- 21 59 +/- 9 
31              CTTCTCCCCGAAACTTTTTCGTTCGGACTC 159 +/- 1 71 +/- 1 
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Figure 10: Basal reporter gene expression levels of pEAL08-2 wildtype and –mutant plasmid in E.coli 
and PA. Data represent the mean values and standard deviations of at least two experiments with 
n=4. 
Interestingly, the 6 bp alteration in site I caused a strong decrease of PQS-induced 
transcriptional activation (Figure 11 A & C) which is in accordance with impaired DNA 
binding ability in in vitro FP assay (Figure 9, Table 1, fragment 1). In a similar fashion, 
the basal β-galactosidase level of E. coli cells harboring wild-type plasmid pEAL08-2 
is reduced in response to increasing concentrations of compound 2. Furthermore, 
switching to the plasmid with the 6 bp mutation within the promotor site leads to a 
heterologous system which is not responsive to compound 2 anymore (Figure 11 B & 
D). Finally, we obtained comparable results with mutated and wild-type plasmids 
(pEAL08-2/ mutated pEAL08-2) introduced in PQS-deficient P. aeruginosa PA14 
ΔpqsA strain. While the transcriptional activity of PqsR could be induced (addition of 
PQS) or suppressed (addition of compound 2) using the wild-type plasmid, 
compound 2 did not have a repressive effect on β-galactosidase expression when 
the addressed 6 bp were mutated. The transcriptional activation was only slightly 
enhanced under addition of PQS. Furthermore, a strong decrease in basal activity 
was observed (Figure 10). To conclude, the observed impacts of mutations on the 
transcriptional activity of the promotor suggest that site I is mandatory for productive 
binding of PqsR in the whole cell environment. 
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A                                                                                              B 
C                                                                                               D 
 
Figure 11: Reporter activity of E. coli DH5α (A & B) and P. aeruginosa PA14 ΔpqsA cells (C & D) 
harboring plasmid pEAL08-2 with native or mutated binding site I within the pqsA promotor. β-
galactosidase activity was quantified in the absence or presence of either PQS (A & C) or compound 2 
(B & D) and is represented as factor of galactosidase activity increase in relation to basal level (=0). 
Data represent the mean values and standard deviations of at least two independent experiments with 
n=4. 
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Discussion 
Fluorescence polarization (FP) assays can be used to investigate interactions of 
macromolecules with a variety of ligands (for a review see Lea and Simeonov, 2011). 
The smaller interaction partner is labelled with a fluorescence probe which is excited 
with linear polarized light. Due to the free rotation of the unbound labelled ligand 
depolarization of the emitted light occurs. If the dye-conjugated molecule binds to a 
macromolecular partner, its rotational speed is decreased due to the higher mass of 
the resulting ligand-receptor complex. This leads to an increase of anisotropy of the 
emitted light and, thus, higher fluorescence polarization. This change in polarization 
of emitted light upon binding can be detected using fluorescence spectrometers 
equipped with polarization filters and used to determine binding affinities. If the mass 
difference between the interaction partners is big enough, even macromolecule-
macromolecule interactions (e.g. between DNA and protein) can be investigated 
(Anderson et al.; Sevenich et al., 1998);. Hence, FP was the method of choice to gain 
more insight into the molecular recognition events between transcriptional regulator 
PqsR and the respective promotor DNA. In the present study, the application of 
fluorescence polarization for quantitative protein-DNA analysis in combination with 
mutated nucleotides led to the identification of two distinct adjacent PqsR binding 
sites. We have found that site I seems to be a hotspot for PqsR-DNA interaction 
regardless of the presence of agonist, inverse agonist, or simply no ligand. The co-
inducer PQS, however, induces binding to an additional site II, which has been 
reported to be important for transcription activation as evidenced by in vivo gene 
expression experiments (Xiao et al., 2006a). Although fluorescence-polarization-
based quantitative protein-DNA analysis does not consider supercoiled DNA as in the 
in vivo situation, it represents a rapid and facile method to gain insight into interaction 
propensities between these biomacromolecules. Through highlighting novel regions 
of affinity within the promotor sequence, our results further support the perception of 
a transcriptional activation mechanism proposed for some other functionally 
characterized LTTR proteins (Muraoka et al., 2003; Lochowska et al., 2001). The 
presence of the applied inverse agonists of differing structural scaffolds led to an 
interaction profile of PqsR on DNA similar to unliganded PqsR. As a major difference 
to apo PqsR, however, the receptor-DNA interaction was strongly enhanced using a 
specific 51 bp oligomer when the inverse agonist was present. The data suggest that 
inverse agonists arrest PqsR in an unproductive state. Presumably, this prevents 
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favorable contacts between the regulator and RNA polymerase at site II of the pqsA 
promotor region essential for transcriptional activation (Tropel and van der Meer, 
2004). The interaction with an enlarged DNA region upon PQS binding might be the 
result of conformational switches which render the regulator capable of binding to the 
divergent recognition element. Another possibility could involve a second binding site 
that is addressed under addition of the inverse agonist, located upstream or 
downstream of the promotor region. However, the exact mechanism of transcriptional 
activation and repression remains to be elucidated. It has to be noted, that a possible 
influence of the MBP-tag within the used full-length PqsR construct on the protein-
DNA interaction cannot be ruled out completely. However, results presented in this 
work strongly support that the general interaction characteristics of PqsR are not 
impaired: The homotetrameric quaternary structure observed in our chemical 
crosslinking experiments is typical for most LTTRs and the affinity of the natural 
ligand PQS to this full-length MBP-tagged construct is similar to the one determined 
for the soluble (crystallizable) ligand binding domain. Hence, the general fold of the 
protein should not be affected by the tag. Importantly, we determined a substantial 
affinity to the LTTR box binding motif indicating that the expected binding capabilities 
have been conserved qualifying this construct as a suitable tool to facilitate 
interaction studies. To understand ligand-dependent structural changes responsible 
for differential DNA interaction, X-ray structures of full-length PqsR in complex with 
target DNA and PqsR ligands would be of great interest. Nevertheless, the results 
provide an exciting example of mechanism of action of an inverse agonist acting on 
this important anti-virulence target on a molecular basis and close a knowledge gap 
between ligand-protein interaction and functional response. These novel insights 
offer new perspectives for future anti-virulence drug development to fight the clinically 
highly relevant pathogen Pseudomonas aeruginosa.  
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Materials and methods 
Construction of PqsR expression vector 
A 1040 bp DNA fragment containing the pqsR gene of P .aeruginosa PAO1 was 
amplified using primers P1 and P2 (Sigma Aldrich, Germany) (Table 5). After 
digestion with MfeI and EcoRI, the yielded fragment was cloned into the MfeI 
restriction site of pMALC5e vector (New England Biolabs, Germany) using T4 DNA 
ligase (Invitrogen, Germany). Restriction enzymes were purchased from New 
England Biolabs, Germany. 
Table 5 Primers used in this study. Restriction sites are underlined. 
name sequence 5´  3´ 
 
function 
P1 TAACAATTGCACACAGGAAACAGAATT 
 
pqsR forw (MfeI) 
 P2 TGGAGAATTCTCTACTCTGGTGCGGCGCG 
 
pqsR rev (EcoRI) 
P3 GAGACCCGGGCTGCAGCAATTGGGAAGCCTGCAAATGGCAGGCGAGGC 
 
overlap fragment 
1 (f) 
 
P4 GATATTCGGAGTCCGAACGAGGGGACTTCGGGGAGAAGAACCACGGGCTTC 
 
overlap fragment 
1 (r) 
 
P5 GAAGCCCGTGGTTCTTCTCCCCGAAGTCCCCTCGTTCGGACTCCGAATATC 
 
overlap fragment 
2 (f) 
 
P6 GAGAGTCGACGACAGAACGTTCCCTCTTCAGCGATATGC 
 
overlap fragment 
2 (r) 
 
Heterologous expression and purification of PqsR 
100 ml of LB medium containing 100 µg/ml of Ampicillin were inoculated with E. coli 
BL21 (λDE3) harboring PqsR-MBP expression plasmid. Cultures were incubated 
over night at 37°C and 150 rpm. 1 liter of TB medium containing 100 µg/ml Ampicillin 
was inoculated with 10 ml of overnight culture and cells were grown until an OD600 ~ 
0.5 at 37°C and 150 rpm. To start the protein expression, IPTG was added at a final 
concentration of 0.3 mM and cells were incubated for 14 h at 22°C and 150 rpm. 
Cells were harvested through centrifugation for 20 min at 4000 xg, 8°C. The pellet 
was resuspended in 100 ml of lysis buffer (25 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 
mM β-mercaptoethanol and 0.5 mM PMSF). Resuspended cells were lysed using a 
french press. The yielded lysate was centrifuged at 25000 xg for 20 minutes at 4°C 
and filtered through a 0.45 µM syringe filter prior to FPLC purification. Purification of 
C-terminal MBP-tagged PqsR was performed in a two-step purification using FPLC 
(Äkta pure, GE Healthcare Lifesciences, Germany). Initially, an affinity 
chromatography using MBPTrap HP column (GE Healthcare Lifesciences) was 
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performed with 20 mM Tris, pH 8.0, 200 mM NaCl, 1 mM EDTA, 0-10 mM maltose. 
This was followed by a second purification step via FPLC size exclusion 
chromatography using HiLoad 16/600 Superdex 200 column (GE Healthcare 
Lifesciences, Germany) in 20 mM Tris, pH 8.0, 1 mM EDTA. Protein aliquots were 
frozen in liquid nitrogen and stored at -80 °C in 20 mM Tris, pH 8.0, 1 mM EDTA, 10 
% glycerol. Purity of the protein was verified using SDS PAGE. 
Construction of pEAL08-2 mutant reporter gene plasmid 
DNA fragments of the pqsA promotor were PCR amplified using primer pairs P3/P4 
and P5/P6 (Sigma Aldrich, Germany) as sown in table 5. The two amplified 
fragments were fused by overlap PCR. Finally, the overlap PCR product was cloned 
into the XhoI and SalI restriction sites of plasmid pEAL08-2 (Cugini et al., 2007) to 
yield pEAL08-2 mutant plasmid. Restriction enzymes were purchased from New 
England Biolabs, Germany. 
Reporter gene assays in E.coli and P. aeruginosa 
pEAL08-2 plasmid harboring pqsR and β-galactosidase lacZ gene under control of 
the pqsA promotor or the pEAL08-2 mutant plasmid were transformed in E.coli DH5α 
and in a P. aeruginosa PA14 ΔpqsA transposon mutant strain. Assays were 
performed as previously described (Lu et al., 2014b). IC50 values were calculated 
using Origin 9G software. 
Determination of extracellular levels of HHQ in P. aeruginosa 
For the quantification of extracellular HHQ levels, a previously reported method was 
used (Lu et al., 2014b) following an altered procedure (Lépine et al., 2003; Lépine et 
al., 2004) A P. aeruginosa PA14 ΔpqsH culture was grown for 17 h at 37°C in the 
presence of a DMSO control or compound respectively. 4-alkyl quinolones were 
extracted with ethyl acetate and quantified using 5,6,7,8-tetradeutero-2-heptyl-4(1H)-
quinolone (HHQ-d4) as internal standard. Analysis was performed as described 
before (Storz et al., 2012) using UHPLC-MS/MS. The following ions were monitored 
(mother ion [m/z], product ion [m/z], scan time [s], scan width [m/z], collision energy 
[V], tube lens offset [V]): HHQ: 244, 159, 0.5, 0.01, 30, 106; HQNO: 260, 159, 0.1, 
0.01, 25, 88; HHQ-d4 (IS): 248, 163, 0.1, 0.01, 32, 113. Data analysis was conducted 
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using Xcalibur software. Given data represent the mean of at least two independent 
experiments with measured triplicate values. 
Fluorescence polarization assay 
Fluorescein-labeled and unlabeled single-stranded DNA was purchased from Sigma 
Aldrich, Germany. Double-stranded oligonucleotides were prepared by annealing 
equimolar amounts of sense and antisense strands in 10 mM Tris, pH 7.9 followed by 
heating to 95°C for 6 minutes. Mixtures were allowed to cool down to room 
temperature for two hours. PqsR was diluted to 2 µM in 20 mM Tris, pH 8.0, 1 mM 
EDTA. The final mixture contained 10 nM fluorescein-labeled DNA, 1 µM PqsR and 
either compound 1 (5 µM) or 2 (10 µM) or DMSO as solvent control. Reactions were 
incubated for 2 hours at 25°C and fluorescence polarization was measured using 
BMG Labtech ClarioStar (BMG Labtech, Germany). Kd values of PqsR and 
fluorescein-labeled DNA fragments were determined using 10 nM labeled DNA under 
addition of PqsR (0 – 5.6 µM), incubated with either DMSO or agonist respectively. 
For competition experiments, mixtures of 0.4 µM or 1 µM purified protein, 10 nM 
fluorescein-labeled DNA, unlabeled competitor DNA (0 – 25 µM) and DMSO or 2 µM 
PQS or 10 µM compound 2 were prepared. All reactions were incubated for 2h at 
25°C. Fluorescence polarization was measured using a BMG ClarioStar platereader 
adjusted to λex = 485 nm and λem=520 nm. Kd values for the unlabeled DNA 
fragments were calculated using equations (1) and (2). 
Equation (1): 
 
Equation (2): 
 
 
Using equation (1) (Invitrogen Corporation, 2006), the amount of labeled DNA bound 
to PqsR ( ) can be calculated. The EC50 values derived from the competition 
experiments for the unlabeled DNA fragments can be transformed in Kd values using 
equation (2) (Nikolovska-Coleska et al., 2004). In direct titration experiments using 
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the labeled DNA fragment and PqsR under addition of compound 2 (100 µM), the Kd 
of the labeled DNA was determined to be 201 nM. Variables: = Kd determined for 
the labeled DNA fragment;  = concentration of labeled DNA; = concentration of 
the receptor; = IC50 from the competition experiment; = affinity of the 
unlabeled DNA fragment. Curve fitting was done using OrigonPro2015 and MARS 
data analysis software (BMG Labtech). 
Cross-linking study  
Crosslinking was conducted by the addition of 25 µM of 
bis[sulfosuccinimidyl]suberate to 5 µM PqsR-MBP. Reaction was carried out in 
phosphate-buffer (34 mM NaCl, 100 mM K2HPO4, pH 7.4, 2.7 mM KCl, 18 mM 
KH2PO4) that additionally contained either 1% DMSO or 5 µM of compound 1. Prior 
to addition of BS3, the mixtures were preincubated for 90 min at 25 °C. The reaction 
was quenched in 2 min time intervals by addition of 60 mM Tris and analyzed on a 
12% SDS-PAGE.  
Isothermal Titration Calorimetry 
ITC using purified PqsR-MBP (60 µM in 20 mM Tris, pH 8.0, 1 mM EDTA) and 4-tert-
butyl benzamide was carried out as described before for truncated PqsR (Klein et al., 
2012). 
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Chapter 2: Publication A:                                            
“Optimization of anti-virulence PqsR antagonists regarding 
aqueous solubility and biological properties resulting in new 
insights in structure-activity relationships”                            
(DOI: 10.1016/j.ejmech.2014.04.016) 
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Chapter 3: Publication B:                                                                       
“Overcoming the unexpected functional inversion of a PqsR 
antagonist in Pseudomonas aeruginosa: an in vivo potent 
antivirulence agent targeting pqs quorum sensing”                    
(DOI: 10.1002/anie.201307547) 
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The present thesis describes several studies to explore the nature and functionality of 
compounds interfering with PqsR. Efforts were undertaken to investigate the different 
activities between an  E. coli and PA test system. However, even with potent 
pathogenicity blockers in hand, the underlying molecular mechanism still needs to be 
explored in detail.  
 
Molecular mechanism of inverse agonists 
 
As mentioned in the introduction of this thesis, PqsR requires the autoinducer 
molecules HHQ and PQS for boosting its transcription-promoting activity. While, in 
general, many compounds act as PqsR blockers by competing with the natural 
agonist, the presented work addresses such that, in addition, possess the functional 
properties of inverse agonists (Figure 6). 
 
Figure 6: Examples of agonistic, antagonistic, and inverse agonistic dose-response curves. The basal 
transcription rate is expressed by an increase of 0%. Here, the agonist leads to a concentration-
dependent increase in transcriptional activity (blue curve), while the antagonist is able to compete with 
the agonist to reduce the activity back to the basal expression level (red curve). In contrast, the 
log Concentration 
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inverse agonist lowers the basal expression level (black line) in a concentration-dependent manner 
(black curve). 
 
The functional behavior of basal inverse agonism shown in Figure 6 corresponds to 
that of compound 1 described in chapter 1. As can be seen in chapter 1, as well as in 
publications A & B, almost every antagonistic compound tested for PqsR activity 
additionally possessed an inverse agonistic functionality. Therefore, not only 
preventing the virulence-boosting abilities of HHQ and PQS but also suppressing the 
natural, positive gene-regulating effects of unliganded PqsR. Chapter 1 tried to 
explore the mechanism behind the inverse agonistic functionality that render the 
transcriptional machinery (promotor DNA / (RNAP) / PqsR) inactive. In general, 
LTTRs are proposed to interact with the RNAP in a direct manner causing an 
increase in polymerase activity, which corresponds to gene upregulation (Tropel and 
van der Meer, J.R., 2004). This interaction requires a close position of both RNAP 
and LTTR. The surprising fact that several inverse agonistic ligands increased the 
affinity to the promotor DNA let us hypothesize that PqsR might be locked on the 
promotor DNA in a position that hinders productive PqsR-RNAP interactions. As can 
be seen in Figure 9 of chapter 1, the inverse agonists force PqsR to a binding 
sequence that is located more upstream in relation to the agonist-liganded DNA 
binding site. This switch in binding position might impair the interactions of RNAP and 
regulator due to increased distance.  
 
In vitro versus in cellulo 
 
The finding that inverse agonists of PqsR favor the binding to a defined binding 
pattern that differs from the one observed for the apo and the agonist- liganded form 
allows a possible functional characterization of the ligands in vitro. So far, we used 
cell- based assay systems for the functional characterization of compounds targeting 
PqsR. However, these reporter gene-based test systems suffer from some 
weaknesses. The usage of whole cell systems always includes additional PK barriers 
such as the bacterial cell envelope (Silver, 2011). This actually might prevent 
compounds with potent target activity from reaching their intracellular target. Even 
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when entering the cell, compounds might be susceptible to metabolic alteration as 
demonstrated in publication B. As a result, potentially promising inhibitors are often 
discarded, without looking for a way to rescue the activity by e.g. turning them less 
prone to metabolization. Furthermore, the results of the β- galactosidase- based 
systems can be misguiding when testing compounds that influence the galactosidase 
enzyme itself. In contrast, the in vitro based approach using purified protein allows a 
verification of on-target activity. In this setup, no PK issues like the disturbing cell wall 
barrier, efflux pumps, or metabolizing enzymes are present. However, the fact that it 
only allows a qualitative statement regarding the functionality depicts a disadvantage 
of this method. Compounds that alter the binding affinity to different DNA fragments 
depending on their functionality (as shown in Figure 6 of chapter 1) could be 
characterized as antagonists or agonists. In case of diverse PqsR ligands, the 
titration of defined mutated DNA fragments would yield altered DNA affinities 
depending on the ligand functionality (agonist or inverse agonist). Additionally, the 
identification of novel DNA promotor sequences that are addressed by the regulator 
under addition of different ligands is also an option. However, a quantitative 
assessment of a compound’s functional activity (e.g., determination of its IC50) 
requires distinct methods like the former mentioned reporter gene tests. For this 
purpose, the use of cell- based assays represents a powerful tool, not only for PqsR 
agonists and antagonists. This highlights the general necessity for a combination of 
both, cell- based and cell- free test systems. The usage of only one setup does not 
guarantee an exclusion of false positive or false negative results.  
 
Novel anti- virulence compounds  
 
In publications A and B, we reported on potent PqsR antagonists derived from 
natural quinolone-based coinducers. This compound class presented the first potent 
PqsR antagonists (Lu et al., 2012). The HHQ derivative harboring a nitro substituent 
in 6-position of the quinolone core (6-NO2-HHQ or compound 1 from publication B) 
served as starting point for the development of PqsR antagonists with improved 
potency. While the above-mentioned compound possessed a nanomolar IC50 in the 
E. coli based reporter gene system, we unexpectedly observed a dramatic decrease 
in activity in the P. aeruginosa background by more than 200- fold. This lack of 
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activity also correlated with poor effects on virulence factor production (Lu et al., 
2014b). Besides the possibility of an altered PK profile due to the different organisms, 
we also thought of pharmacodynamic effects caused by P. aeruginosa. The usage of 
Liquid Chromatography Mass Spectrometry (LCMS-MS) based methods revealed 
that the monooxygenase PqsH converted compound 1 into the hydroxylated 
metabolite 2. In addition to the depletion of the antagonistic compound, the formed 
metabolite exhibited a strong agonistic functional profile (EC50 = 2.8 nM), being 
around 2- fold more potent than the natural ligand PQS. In that way, the bacteria 
were able to synthesize a “superagonist” (Galloway, Warren R J D et al., 2012) that 
enhanced the activity of the PQS QS. This finding forced us to improve the metabolic 
stability of compound 1 against a PqsH- mediated hydroxylation. Therefore, a 
carboxamide substituent was introduced in the susceptible 3- position of the 
quinolone core. The yielded compound 3 not only possessed good activity in E. coli 
but also showed high potency in Pseudomonas with simultaneously enhanced 
reduction of virulence factor formation. This strategy rehabilitated the quinolone 
compound class as potent anti- virulence agents and highlights the importance for 
the combination of different assay systems.  
However, all of the identified antagonists with increased potency (Lu et al., 2012; Lu 
et al., 2014b) suffered from poor physicochemical properties, especially regarding 
water solubility. Publication A addressed this problem by trying several strategies to 
improve this parameter. E. coli-based reporter gene experiments monitoring the 
functional properties of the derivatives in combination with High Performance Liquid 
Chromatography (HPLC)-based solubility tests guided the structural optimization 
process. For the majority of the synthesized derivatives, we observed only weak to 
moderate antagonistic activity at simultaneously increased water solubility. This 
phenomenon might be caused by permeation issues regarding the possibility that 
hydrophilic compounds cannot easily pass the cell layer. Another possible 
explanation might be given when looking at a reported crystal structure with the HHQ 
derivative NHQ (Ilangovan et al., 2013). Here, a hydrophobic pocket that harbors the 
lipophilic alkyl chain part of NHQ forms an important space for the ligand- receptor 
interaction. In case of more hydrophilic derivatives this hydrophobic pocket would be 
less favorable for interactions in contrast to the lipophilic NHQ sidechain. 
Nevertheless, the optimization process yielded compound 16 that possessed 
increased water solubility as well as an IC50 on PqsR in the nanomolar range. 
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Therefore, in combination with the described structure activity relationship (SAR) (Lu 
et al., 2014a) studies, this compound can be regarded as a good starting point for 
future optimization strategies. In parallel, the described SAR allows a better 
understanding and deeper insight into the functional nature of different PqsR ligands. 
However, the exact structural properties that render compounds agonists or 
antagonists still have to be elucidated. In addition to the findings described in the 
present thesis, discussions regarding synthesis and solubility properties as well as 
biological activities of the different compounds from publications A and B were 
described by my colleagues Dr. Cenbin Lu (Lu, 2014) and Dr. Christine K. Maurer 
(Maurer, 2015) in their dissertations. 
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These studies contributed to a better understanding of the complex regulatory 
transcriptional machinery. However, to date, the lack of a crystal structure for the full 
length PqsR only allows artificial studies regarding the molecular behavior of the 
receptor. For future investigations, the crystallization of a full length PqsR in complex 
with target promotor DNA and different ligands would be of great interest to the 
community. Finally, the compounds identified and characterized in the present thesis 
are in particular possible candidates for more detailed in vivo studies and should 
therefore be tested in more complex animal models like a mouse model.  
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The present thesis was directed at establishing assay systems for the 
characterization of PqsR and its ligands. The conducted reporter gene experiments 
identified various agonistic and antagonistic compounds with, high potency in 
Pseudomonas aeruginosa. As presented in publication B, an unexpected change in 
the functional activity could be explained by cell- mediated hydroxylation. This fact 
demonstrates how bacteria can inactivate an anti-virulence agent and turn it into a 
compound even favoring the virulence. The quinolone-based antagonists turned out 
to suffer from poor physicochemical properties, especially regarding water solubility. 
Publication A intended to address this issue and as a result, several compounds with 
improved solubility/antagonistic activity profile were obtained. Chapter 1 pointed 
towards exploring the origin of the inverse agonistic effects. Using a fluorescence 
polarization-based in vitro assay, it could be shown that these inverse agonistic 
characteristics are presumably caused by locking the regulator PqsR at a formerly 
unknown binding sequence on the promotor DNA. Furthermore, it was shown that the 
apo- and the agonist- liganded forms of PqsR occupy the same binding sequence, 
while the antagonist- liganded form binds to a more narrow region.  
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Die vorliegende Arbeit beschäftigt sich mit der Entwicklung von Testsystemen zur 
Identifizierung und Charakterisierung von PqsR Liganden. Die durchgeführten 
Reportergenassay Experimente führten zur Identifikation verschiedener, 
agonistischer und antagonistischer Verbindungen mit teilweise nanomolaren 
Aktivitäten in Pseudomonas aeruginosa. Wie in Publikation B beschrieben, konnte 
der Verlust an Aktivität in Pseudomonas aeruginosa auf bakteriellen Metabolismus 
zurückgeführt werden. Eine gezielte Modifikation der Verbindung stellte die Aktivität 
wieder her. Publikation A verfolgte das Ziel, Verbindungen mit besserer 
Wasserlöslichkeit bei gleichzeitigem Erhalt der antagonistischen Aktivität 
herzustellen. Kapitel 1 beschäftigte sich mit dem Phänomen des inversen 
Agonismus, eine Wirkweise, die mehrere der hier beschriebenen PqsR Antagonisten 
besitzen. Mit Hilfe eines in vitro Fluoreszenzpolarisationsassays, konnte gezeigt 
werden, dass diese invers agonistischen Aktivitäten möglicherweise durch Einfrieren 
einer bestimmten Konformation des Regulators PqsR zustande kommen. Der 
Regulator bindet in Anwesenheit dieser inversen Agonisten an eine bisher 
unbekannte Bindestelle auf der Promotor DNA, wodurch eventuell produktive 
Interaktionen mit der RNA Polymerase verhindert werden.  
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AHL N-acyl L-homoserine lactone 
BS3 bis[sulfosuccinimidyl]suberate 
CF Cystic Fibrosis 
Cpd. Compound 
DMSO Dimethyl sulfoxide 
FP Fluorescence Polarization 
HHQ 2-heptyl-4(1H)-quinolone 
HHQ-d4 5,6,7,8-tetradeutero-2-heptyl-4(1H)-quinolone 
HPLC High Performance Liquid Chromatography 
HTH Helix-Turn-Helix 
IC50 Half maximal inhibitory concentration 
ITC Isothermal Titration Calorimetry 
Kd Dissociation constant 
kDa Protein mass in Kilo-Dalton 
LCMS-MS Liquid Chromatography Mass Spectrometry 
LTTR LysR-Type Transcriptional Regulator 
MBP Maltose-Binding Protein 
MvfR Multiple Virulence factor Regulator 
ONP Ortho- Nitrophenol 
ONPG Ortho- Nitrophenol β-D-Galactospyranoside 
PA Pseudomonas aeruginosa 
PAGE Polyacrylamide gel electrophoresis 
PQS 3-hydroxy-2-heptyl-4(1H)-quinolone 
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PqsR Pseudomonas Quinolone Signal Receptor 
QS Quorum Sensing 
QSI Quorum Sensing Inhibitor 
RNAP RNA Polymerase 
SDS Sodium dodecyl sulfate 
SPR Surface Plasmon Resonance 
TSS Transcriptional Start Site 
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Fig. S1: 1H NMR spectra (500 MHz, CDCl3) of 2-heptyl-4-methoxyquinoline (compound 3) 
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Fig. S2: 13C NMR spectra (125 MHz, CDCl3) of 2-heptyl-4-methoxyquinoline (compound 3) 
 
Fig. S3: 1H NMR spectra (500 MHz, MeOH-d4) of 2-heptyl-1-methyl-6-(trifluoromethyl)quinolin-
4(1H)-one (compound 4)
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Fig. S4: 13C NMR spectra (125 MHz, MeOH-d4) of 2-heptyl-1-methyl-6-(trifluoromethyl)quinolin-
4(1H)-one (compound 4) 
 
Fig. S5: 1H NMR spectra (500 MHz, MeOH-d4) of 6-nitro-2-(pentyloxymethyl)quinolin-4(1H)-one 
(compound 8) 
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Fig. S6: 13C NMR spectra (125 MHz, MeOH-d4) of 6-nitro-2-(pentyloxymethyl)quinolin-4(1H)-one 
(compound 8) 
 
Fig. S7: 1H NMR spectra (500 MHz, MeOH-d4) of 2-(4-ethoxybutyl)-6-nitroquinolin-4(1H)-one 
(compound 11) 
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Fig. S8: 13C NMR spectra (125 MHz, MeOH-d4) of 2-(4-ethoxybutyl)-6-nitroquinolin-4(1H)-one 
(compound 11) 
 
Fig. S9: 1H NMR spectra (500 MHz, DMSO-d6) of 2-heptyl-3-hydroxy-6-nitroquinolin-4(1H)-one 
(compound 14) 
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Fig. S10: 13C NMR spectra (125 MHz, DMSO-d6) of 2-heptyl-3-hydroxy-6-nitroquinolin-4(1H)-one 
(compound 14) 
 
Fig. S11: 1H NMR spectra (500 MHz, DMSO-d6) of 2-heptyl-3-(hydroxymethyl)-6-nitroquinolin-4(1H)-
one (compound 16) 
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Fig. S12: 13C NMR spectra (125 MHz, DMSO-d6) of 2-heptyl-3-(hydroxymethyl)-6-nitroquinolin-
4(1H)-one (compound 16) 
 
Fig. S13: 1H NMR spectra (500 MHz, MeOH-d4) of ethyl 2-heptyl-6-nitro-4-oxo-1,4-dihydroquinoline-
3-carboxylate (compound 18) 
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Fig. S14: 13C NMR spectra (125 MHz, MeOH-d4) of ethyl 2-heptyl-6-nitro-4-oxo-1,4-
dihydroquinoline-3-carboxylate (compound 18) 
 
Fig. S15: 1H NMR spectra (500 MHz, DMSO-d6) of 2-heptyl-6-nitro-4-oxo-1,4-dihydroquinoline-3-
carboxylic acid (compound 22) 
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Fig. S16: 13C NMR spectra (125 MHz, DMSO-d6) of 2-heptyl-6-nitro-4-oxo-1,4-dihydroquinoline-3-
carboxylic acid (compound 22) 
 
Fig. S17: 1H NMR spectra (500 MHz, DMSO-d6) of 2-heptyl-6-nitro-4-oxo-1,4-dihydroquinoline-3-
carboxamide (compound 26) 
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Fig. S18: 13C NMR spectra (125 MHz, DMSO-d6) of 2-heptyl-6-nitro-4-oxo-1,4-dihydroquinoline-3-
carboxamide (compound 26) 
 
Fig. S19: 1H NMR spectra (500 MHz, DMSO-d6) of 2-heptyl-N-hydroxy-6-nitro-4-oxo-1,4-
dihydroquinoline-3-carboxamide (compound 28) 
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Fig. S20: 13C NMR spectra (125 MHz, DMSO-d6) of 2-heptyl-N-hydroxy-6-nitro-4-oxo-1,4-
dihydroquinoline-3-carboxamide (compound 28) 
 
Fig. S21: 1H NMR spectra (500 MHz, DMSO-d6) of 2-heptyl-1,6-naphthyridin-4(1H)-one (compound 
31) 
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Fig. S22: 13C NMR spectra (125 MHz, DMSO-d6) of 2-heptyl-1,6-naphthyridin-4(1H)-one (compound 
31) 
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